Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹225.75Admitted-Finance B 1 ANSAL CHAMBER 1 BHIKAJI CAMA PLACE DELHI NEW DELHI 110066 SOUTH WEST DELHI DELHI 110066 | NEW DELHI | DELHI | 110066 | ₹225.75 | L1 | Admitted-Finance |
| 2 | L2₹774+₹548.25 (242.9%)Admitted-Finance | ₹774+₹548.25 (242.9%) | L2 | Admitted-Finance |
| 3 | L3₹11,365.99+₹11,140.24 (4934.8%)Admitted-Finance | ₹11,365.99+₹11,140.24 (4934.8%) | L3 | Admitted-Finance |
| 4 | L4₹39,043.64+₹38,817.89 (17195.1%)Admitted-Finance 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | ₹39,043.64+₹38,817.89 (17195.1%) | L4 | Admitted-Finance |
| 5 | L5₹42,131.25+₹41,905.50 (18562.8%)Admitted-Finance S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | ₹42,131.25+₹41,905.50 (18562.8%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | South End Trade Links L6 | LIFE CARE L2 | INDEX INDIA SURGICALS AND PHARMACEUTICAL SERVICES L3 | SUPREME INTERNATIONAL PHARMACEUTICALS L1 | Dr Reddys Laboratories Limited L4 | Medikon India Private Limited L5 |
|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj Romosozumab 210 mg | 1 | PFS | - | - | - | - | 22,405 ₹23,525.25 Lowest | - |
| 2.00 | Inj Evolocumab 140 mg | 2 | Vial | - | - | - | - | 15,518.39 ₹15,518.39 Lowest | - |
| 3.00 | Tab Crizotinib 250 mg | 1 | No | - | - | - | 215 ₹225.75 Lowest | - | - |
| 4.00 | Tab Selexipag 200 mg | 2 | No | 64.8 ₹68.04 Lowest | - | - | - | - | - |
| 5.00 | Inj Tirzepatide 2.5 mg | 1 | PFS | - | - | - | - | - | 10,500 ₹11,025 Lowest |
| 6.00 | Inj Tirzepatide 5 mg | 2 | PFS | - | - | - | - | - | 13,125 ₹13,781.25 Lowest |
| 7.00 | Inj Tirzepatide 10 mg | 1 | PFS | - | - | - | - | - | 16,500 ₹17,325 Lowest |
| 8.00 | Inj Atezolizumab 1875 mg | 2 | Vial | 2,64,034 ₹2,64,034 Lowest | - | - | - | - | - |
| 9.00 | Tab L Carnosine 400 mg | 1 | No | - | - | - | - | - | - |
| 10.00 | Tab Entrectinib 200 mg | 2 | No | 4,298.92 ₹4,298.92 Lowest | - | - | - | - | - |
Tender Value
Refer Docs
Closing Date
1 Aug 2026, 10:00 amClosed
COMMANDING OFFICER
MH TRIVANDRUM
PROCUREMENT OF MEDICAL STORES
2026_ARMY_780893_1
200294/DGLP/ECHS/IFA/92/2026
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
MH TRIVANDRUM
AS PER TENDER DOCUMENTS
3 documents required · 3 mandatory
₹0
Exempted
5 Aug 2026
25 Jul 2026
1 Aug 2026
25 Jul 2026
1 Aug 2026
25 Jul 2026
25 Jul 2026 - 1 Aug 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Inj Romosozumab 210 mg | 1 | PFS | - | - |
| 2 | Inj Evolocumab 140 mg | 2 | Vial | - | - |
| 3 | Tab Crizotinib 250 mg | 1 | No | - | - |
| 4 | Tab Selexipag 200 mg | 2 | No | - | - |
| 5 | Inj Tirzepatide 2.5 mg | 1 | PFS | - | - |
| 6 | Inj Tirzepatide 5 mg | 2 | PFS | - | - |
| 7 | Inj Tirzepatide 10 mg | 1 | PFS | - | - |
| 8 | Inj Atezolizumab 1875 mg | 2 | Vial | - | - |
| 9 | Tab L Carnosine 400 mg | 1 | No | - | - |
| 10 | Tab Entrectinib 200 mg | 2 | No | - | - |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.19 MB
RFPIFA92.pdf
Tender Documents • 1.26 MB
BOQ_874757.xls
BOQ • 0.37 MB
ManufacturerQuoted.xls
Additional Documents • 0.07 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .